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Abstract
Membrane vesicles (MVs) produced by Gram-negative bacteria are being explored for
novel clinical applications due to their ability to deliver active molecules to distant host cells,
where they can exert immunomodulatory properties. MVs released by the probiotic Escheri-
chia coli Nissle 1917 (EcN) are good candidates for testing such applications. However, a
drawback for such studies is the low level of MV isolation from in vitro culture supernatants,
which may be overcome by the use of mutants in cell envelope proteins that yield a hyperve-
siculation phenotype. Here, we confirm that a tolR mutation in EcN increases MV produc-
tion, as determined by protein, LPS and fluorescent lipid measurements. Transmission
electron microscopy (TEM) of negatively stained MVs did not reveal significant differences
with wild type EcN MVs. Conversely, TEM observation after high-pressure freezing followed
by freeze substitution of bacterial samples, together with cryo-TEM observation of plunge-
frozen hydrated isolated MVs showed considerable structural heterogeneity in the EcN tolR
samples. In addition to common one-bilayer vesicles (OMVs) and the recently described
double-bilayer vesicles (O-IMVs), other types of MVs were observed. Time-course experi-
ments of MV uptake in Caco-2 cells using rhodamine- and DiO-labelled MVs evidenced that
EcN tolR MVs displayed reduced internalization levels compared to the wild-type MVs. The
low number of intracellular MVs was due to a lower cell binding capacity of the tolR-derived
MVs, rather than a different entry pathway or mechanism. These findings indicate that het-
erogeneity of MVs from tolR mutants may have a major impact on vesicle functionality, and
point to the need for conducting a detailed structural analysis when MVs from hypervesicu-
lating mutants are to be used for biotechnological applications.
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Introduction
Commensal and pathogenic Gram-negative bacteria have evolved different systems to contact
host cells. One mechanism is the formation of membrane vesicles that can deliver the cargo to
distant targets in the host [1]. Bacterial membrane vesicles (MVs) are spherical membranous
structures with diameters ranging between 20 and 300 nm. Produced during the normal
growth of Gram-negative bacteria, they enable a protected secretion of proteins, lipids, RNA,
DNA and other effector molecules [2,3]. Many studies with Gram-negative pathogens con-
ducted in the last decade have shown that MVs are internalized in host cells and contribute to
virulence by delivering cytotoxic factors as well as mediators that interfere with the immune
system [4,5]. When first discovered, MVs from pathogenic bacteria were proposed as vaccines,
and research in this field continues [6–8]. Promising novel therapy applications include using
engineered MVs expressing antigens from pathogenic strains or as specialized drug delivery
vehicles [9,10].
One drawback for functional and applied studies with MVs is the low yield of vesicles
recovered from in vitro culture supernatants. Different strategies have been assayed to improve
yields, such as growing bacteria under stressed conditions, in the presence of antibiotics, or the
use of mutants in components of the cell envelope [11–15]. MV formation takes place after the
outer membrane is detached from the peptidoglycan (PG) located in the periplasmic space.
For this reason, crosslinking of the PG with membrane components is needed for cell stability
and has been studied extensively. The PG interacts with the outer membrane porin OmpA and
with the Tol-Pal protein complex, and establishes covalent cross-linking with Brauns’s lipopro-
tein (Lpp). Under natural conditions, changes in the interaction between these envelope
components without disturbance of the membrane stability are described as crucial for MV
biogenesis. With the aim of increasing MV production, different groups have obtained
mutants in genes encoding cell envelope proteins. Thus, ompA mutants of Escherichia coli, Vib-
rio cholerae, and Acinetobacter baumannii [16–18], as well as tol-pal mutants of E. coli and
Helicobacter pylori [19,20] have been reported as “hypervesiculating” strains, suitable for a
high production of MVs under different growth conditions. A recent study analyzing MV pro-
duction by the mutant strains of the Keio Collection identified around 150 genes involved in
the vesiculation process. It was shown that mutations altering outer membrane structures gen-
erally lead to hypervesiculation phenotypes [21].
There is a need to characterize and quantify the MVs obtained from over-producing phe-
notypes. Different methods have been used to measure vesiculation levels but generally
without clarifying the MV structure and composition [1]. In most published studies, MV
morphology and integrity is revealed by transmission electron microscopy (TEM) micro-
graphs from negatively stained MVs [13,19,22,23]. Although this technique is useful to con-
firm the presence of MVs, the resolution is insufficient to visualize irregular or atypical MVs,
which may be obtained when working with genetically manipulated strains. Hypervesiculat-
ing mutants can produce atypical MVs, which may have surface antigens with a different
conformation or display altered immunogenicity, self-adjuvation, or uptake by host cells.
The variability caused by these features can affect studies evaluating the application of MVs
in different fields [8–10].
In recent years, improvements in TEM and cryo-TEM techniques have enabled the imaging
of biological specimens with greatly enhanced resolution. TEM observation of specimens
cryoimmobilized by High Pressure Freezing (HPF) followed by Freeze Substitution (FS) and
sectioning, together with cryo-TEM observation of frozen-hydrated specimens, allow visuali-
zation of biological samples close to their native state, enabling us to refine our knowledge of
bacterial structures [24,25]. These techniques enabled us to visualize the formation of a new
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type of MVs in environmental and pathogenic bacteria [26,27], and may therefore be useful to
characterize the fine structure of MVs from hypervesiculating strains.
Escherichia coli Nissle 1917 (EcN) is a probiotic used for the treatment of intestinal disor-
ders. Its MVs modulate the cytokine /chemokine response of epithelial and immune cells in
different in vitro and ex vivo models [28]. Moreover, engineered MVs derived from EcN are
being analyzed as recombinant subunit antigen carriers for the development of pathogen-
mimetic vaccines [29]. In this work, we constructed a tolR mutant derived from this probiotic
strain. We analyzed the growth and vesiculation capacity of the EcN tolR mutant, and structur-
ally characterized its MVs. For this purpose, wild type and tolR mutant EcN, as well as their
derived MVs, were analyzed by TEM after HPF-FS and cryo-TEM. MV uptake by Caco-2 cells
was analyzed as a functional parameter to evaluate whether EcN tolR-derived MVs are effi-
ciently internalized by intestinal epithelial cells.
Materials and Methods
Bacterial strains and cell growth
The probiotic strain EcN (serotype O6:K5:H1) was provided by Ardeypharm GmbH (Her-
decke, Germany). The mutant strain EcN tolR was constructed in this study by P1-transduc-
tion from E. coli strain TPS300 (tolR::Ocm). Gene disruption was confirmed by PCR (S1 Fig).
This mutation does not cause polarity to downstream tolAB genes [30]. For growth monitoring
and MV production, EcN and EcN tolR were routinely grown at 37˚C in Luria-Bertani broth
(LB) in an orbital shaker at 250 rpm. Chloramphenicol (Cm) was added to the medium at
20 μg/ml final concentration. For HPF-FS methods, cells were grown on Trypticase Soy Agar
(TSA, Oxoid) for 18 h at 37˚C. Growth was monitored by measuring the optical density (OD)
at 580 nm. Bacterial cells were counted by plating serial dilutions on LB agar plates.
Isolation of MVs
MVs were isolated from culture supernatants as described previously [31]. Briefly, bacterial
cells were grown aerobically in LB for 15 h and pelleted by centrifugation at 10,000 x g for 20
min at 4˚C. The supernatants were filtered through a 0.22 μm-pore-size filter (Millipore) to
remove residual bacteria and concentrated by centrifugation in a 100K Centricon1 Plus-70 fil-
ter device (Millipore), followed by an additional filtration step. MVs were recovered by centri-
fugation at 150,000 × g for 1 h at 4˚C, washed and resuspended in phosphate buffered saline
(PBS). MVs were again pelleted (150,000 × g, 1 h) and finally resuspended in an adequate vol-
ume of PBS. Sterility of samples was assessed on TSA agar plates.
Quantification of MVs
MVs produced by EcN and EcN tolR from 1L of culture were quantified by three different
methods. Protein concentration was measured by the Lowry method [32]. LPS content was
quantified by the Purpald assay as described previously, using KDO as a standard [33]. Lipid
content associated with MVs was determined using the lipophilic fluorescent dye FM4-64
(Thermofisher) as described previously [34]. Briefly, a portion of the sterile resuspended MVs
was incubated with FM4-64 (5 μg/ml in PBS) for 10 min at room temperature. MVs alone and
the FM4-64 probe alone were used as negative controls. After excitation at 515 nm, emission
at 640 nm was measured with the multiplate reader SYNERGY HT (Biotek). Fluorescence was
normalized by colony forming units (CFU), determined by the dilution plating method. All
quantifications were done by triplicate in three independent experiments.
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Protein identification by LC-MS/MS
MV samples (10 μg protein) were separated by 10% sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) [35], and protein bands were visualized by staining with Sypro1
Ruby Protein Gel Stain (Molecular Probes™), following the protocol of the manufacturer. Dif-
ferential protein bands between samples were excised for protein identification at the Proteo-
mic Platform at The Scientific Park of Barcelona. Protein bands were digested with trypsin and
analyzed in a NanoAcquity (Waters) coupled to LTQ-Orbitrap Velos (Thermo Scientific)
mass spectrometer essentially as described previously [31]. Data were acquired in raw data for-
mat using the software Thermo Xcalibur (v.2.2). A database was created by merging the pro-
tein entries present in the public database Swiss-Prot E. coli (v. 10/10/2016) with a database
containing all entries for E. coli Nissle 1917 from NCBI (v. 10/10/2016). The raw files obtained
in the mass spectrometry analyses were used to search the database described above. The soft-
ware used was Proteome Discoverer (v.1.4.1.14), with Sequest HT as the search engine. Both
target and decoy databases were searched to obtain a false discovery rate (FDR) in order to dis-
criminate between correct and incorrect peptide spectrum matches, using the same q-values as
previously described [31]. The lists of identified proteins for each sample are provided as Sup-
porting Information (S1 Table).
Western Blotting of Lipopolysaccharide (LPS)
Western blot analysis of LPS was performed as described previously, using specific antibodies
against E. coli LPS (Abcam) (1:5,000 dilution, overnight at 4˚C) and donkey anti-rabbit immu-
noglobulin horseradish peroxidase-linked (GE Healthcare) as a secondary antibody (dilution
1:15,000, 1 h at room temperature) [28]. The protein-antibody complex was visualized using
the ECL Plus Western blotting detection system (GE Healthcare).
Negative staining and TEM
Isolated MVs were examined by TEM after negative staining as described previously [36]. For-
mvar/carbon-coated copper grids were activated by UV light. Isolated MVs were adsorbed on
grids for 1 min and then washed with distilled water. Grids were stained with 2% uranyl ace-
tate for 1 min. After rinsing, grids were viewed with a Tecnai Spirit electron microscope (FEI
Company, Netherlands) at an acceleration voltage of 120 kV.
TEM observation after HPF-FS
TEM observation of EcN and EcN tolR strains after HPF-FS was performed as described previ-
ously [34]. For this purpose, cells were grown on TSA agar plates at 37˚C for 18 hours. Briefly,
bacterial colonies were cryoimmobilized using a Leica EMPact high-pressure freezer (Leica,
Austria), and were freeze-substituted in a Leica EM automatic freeze substitution (AFS) system
(Leica, Austria), where the substitution was performed in pure acetone containing 2% (w/v)
osmium tetroxide and 0.1% (w/v) uranyl acetate. Samples were embedded in Epon 812 (Ted
Pella, Inc.). Epon-embedded thin sections were examined in a Tecnai Spirit electron micro-
scope (FEI Company, Netherlands) at an acceleration voltage of 120 kV.
Cryo-TEM analysis of isolated MVs
For cryo-TEM observation of isolated MVs, samples were prepared as described above for MV
isolation from liquid cultures. Cryo-TEM analysis was performed as described previously [27].
Briefly, MV suspensions (5 μl) were applied on freshly glow-discharged Quantifoil R 2/2 grids
(Quantifoil Micro Tools GmbH, Germany) and allowed to adhere for 4 min. The samples
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were vitrified using a Vitroblot (FEI Company, Netherlands), and were transferred to a Tecnai
F20 microscope (FEI Company, Netherlands), using a Gatan cryotransfer system (Gatan Inc.
CA, USA). Cryo-TEM visualizations were carried out at a temperature between −170˚C and
−175˚C and at the accelerating voltage of 200 kV. Images were acquired using low-dose imag-
ing conditions and an Eagle 4k x 4k Images charged-coupled device (CCD) camera (FEI Com-
pany, Netherlands).
MV internalization by Caco-2 cells. The human colonic cell line Caco-2 (ATCC HTB-
37) was obtained from the American Type Culture Collection. Cells were cultured in Dulbec-
co’s Modified Eagle Medium (DMEM) High Glucose supplemented with 10% (v/v) fetal
bovine serum, 25 mM HEPES, 1% non-essential amino acids and penicillin (100 U/ml) and
streptomycin (100 μg/ml) (Gibco BRL). Cultures were incubated at 37˚C with 5% CO2.
To monitor MV internalization in intestinal epithelial cells, MVs were fluorescently labelled
with octadecyl rhodamine B-R18 (Life Technologies) as described previously [28]. MVs, puri-
fied as described above, were washed with PBS, resuspended in labelling buffer (50 mM
Na2CO3, 100 mM NaCl, pH 9.2) in the presence of 1 mg/ml octadecyl rhodamine B-R18 and
incubated for 1 h at 25˚C. Labelled MVs were pelleted by centrifugation at 150,000 × g for 1 h
at 4˚C, resuspended in PBS (0.2 M NaCl) and washed twice to fully remove the unbound dye.
After a final centrifugation step, the rhodamine-labelled MVs were resuspended in PBS (0.2 M
NaCl) containing a protease inhibitor cocktail (Complete Protease Inhibitor Tablet, Roche)
and stored at 4˚C for up to 6 weeks.
MV internalization assays were performed using Caco-2 cells (18–20 days post-confluence)
grown in a 96-well black plate (Corning Incorporated, Costar1). Prior to the assay, the
medium was replaced with rhodamine B-R18-labelled MVs (1 μg protein/well) suspended in
DMEM medium in the absence of phenol red and FCS. Cells were incubated at 37˚C and fluo-
rescence was measured over time using a Modulus™ Microplate Fluorometer (Turner BioSys-
tems) (Ex 570 nm; Em 595 nm). Fluorescence intensity was normalized by the fluorescence of
labelled MVs in the absence of epithelial cells. To determine the mechanism involved in the
internalization process, Caco-2 cells were pre-treated with the endocytosis inhibitors chlor-
promazine (15 μg/ml) or filipin III (10 μg/ml) for 1 h at 37˚C prior to the addition of labeled-
MVs. Control cells were not treated with the inhibitors.
MV internalization was assessed by confocal fluorescence microscopy as previously
described [28,37]. Briefly, Caco-2 cells were grown in an 8-well chamber slider (ibidi) and
incubated with rhodamine B-R18-labelled MVs (1 μg) at 37˚C for 1 h, and then washed with
PBS. Nuclei were labelled with DAPI. To visualize cell boundaries, the peripheral zonula occlu-
dens ZO-1 protein was stained using anti-ZO-1 rabbit IgG antibody (Invitrogen) and Alexa
Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen). Confocal microscopy was carried out
using a Leica TCS SP5 laser scanning confocal spectral microscope with a 63x oil immersion
objective lens. Images were captured with a Nikon color camera (16 bit). Fluorescence was
recorded at 405 nm (blue; DAPI), 488 nm (green; Alexa Fluor 488), and 546 nm (red; rhoda-
mine B-R18). Z-stack images were taken at 0.5 μm. Images were analyzed using the Fiji image
processing package.
For flow cytometry analysis, MVs were labelled with 1% (v/v) fluorescence dye 3–3’-diocta-
decyloxacarbocyanine perchlorate (DiO; Molecular Probes) as described elsewhere [38]. Caco-
2 cells grown to confluence in 12-well tissue culture plates were trypsinized, resuspended in
fresh DMEM without phenol red, and incubated at 37˚C with Dio-labelled MVs (100 μg) for
up to 4 h. To estimate the proportion of internalized MVs, extracellular vesicle fluorescence
was quenched with trypan blue (0.25%). This treatment allows detection of only intracellular
MVs [38]. At the indicated times, samples were taken and fluorescence intensities were mea-
sured using a Beckman Coulter Cytomics FC500 flow cytometer before (total amount of cell-
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associated MVs) and after (internalized MVs) the addition of trypan blue. Cell debris and dead
cells were excluded from analysis by gating cells using FSC vs SSC double dot. A total of 10,000
events were analyzed for each gated sample. Mean fluorescence intensity values of untreated
cells were subtracted from the values of MV-treated cells.
Cell viability assay. The trypan blue exclusion test was used to evaluate the effect of MVs
on cell viability as described previously [37]. Caco-2 cells plated into 24-well plates were
exposed to 5 μg/ml MVs for up to 168 h. As a rule, once every two days, the cells were trypsi-
nized, stained with 0.25% w/v trypan blue, and counted with a haemocytometer.
Results
A tolR mutation in EcN increases MV production
The Tol-Pal system of E. coli is important for the maintenance of outer membrane integrity. It
has been described that mutations in any of the tol-pal genes confer a defect in the outer mem-
brane that leads to increased MV production [19–21].
To improve the MV yield of the probiotic EcN, we constructed a derived tolR defective
mutant by P1 transduction. The donor E. coli strain was TPS300, which carries a Cmr cassette
insertion in the tolR gene (tolR::Ocm) [30]. The mutation was confirmed by PCR (S1 Fig). To
analyze the effect of the tolR mutation on cell growth and viability, growth curves of the wild-
type and mutant strains in LB were measured, and their log-phase doubling times were calcu-
lated. Growth was monitored both by measuring the OD at 580 nm (Fig 1A) and counting via-
ble cells on LB agar plates (S2 Fig). EcN tolR exhibited a slightly higher doubling time (23.3
min) than the wild-type EcN strain (19.3 min). However, no differences between strains were
observed in the early stationary phase. The vesiculation levels of EcN and EcN tolR were com-
pared after 15 h of growth, when both strains achieved an OD580 of 1.7 and cell counts of 4 x
109 CFU/ml. MVs were isolated from cell-free culture supernatants and evaluated by negative
stain-TEM. Images showed spherical MVs, which in the wild-type strain ranged in size from
approximately 20 to 60 nanometers in diameter (Fig 1B). The tolR mutant MVs appeared to be
larger (from 20 to 150 nm) and displayed greater variability in size, with a lower population of
small MVs (Fig 1B).
MV production was estimated by three different methods: protein quantification, LPS
concentration, and fluorescence measured after incubation with the lipid probe FM4-64.
Protein and LPS were normalized for the volume of the culture from which MVs were iso-
lated (1L), and fluorescence was normalized for the amount of bacteria (CFU). Results of
MV quantification are shown in Table 1. All the three methods, revealed statistically signifi-
cant differences in vesiculation between the mutant and the wild-type strains, with 32.9-,
51.95- and 77.78-fold increases for protein, LPS and fluorescence determinations, respec-
tively. Although the protein content was higher in the tolR mutant, the lipidic content was
far higher, and the protein to fluorescence ratio for wild-type and mutant strains gave values
of 362.54 and 157.48, respectively.
Protein profiles of MVs produced by EcN and EcN tolR
To further characterize the MVs isolated from the EcN tolR mutant, the protein profile was
compared to the wild-type EcN strain by SDS-PAGE (Fig 2A). Most of the protein bands were
invariably present in both samples, although some differences were observed. Seven differen-
tial protein bands were excised from the gel, subjected to in-gel trypsin digestion and analyzed
by LC- MS/MS (S1 Table). The name of the protein displaying the highest score in each band
is indicated in Fig 2B. The results showed that the most relevant differences were correlated
with disturbances in outer membrane structures. MVs isolated from the tolR mutant were
Fine Structure and Internalization of Membrane Vesicles from E. coli Nissle 1917 tolR Mutant
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enriched in the peptidoglycan-associated lipoprotein Pal and TolB (bands 4 and 7), but defi-
cient in flagellin and the murein-interacting protein MipA (bands 1 and 3). In both EcN and
EcN tolR MVs the three main protein bands, close to the 40 kDa marker, corresponded to the
outer membrane proteins OmpC, OmpF, NmpC and OmpA. However, the protein displaying
the lowest molecular mass (mainly OmpA) was diminished in the wild-type MVs (band 6).
We also performed Western blot analyses of LPS in both MV samples (Fig 2C). At equal
protein amounts, the LPS content of EcN tolR MVs was higher than that of the wild-type MVs.
These results were consistent with the LPS concentration values calculated by the Purpald
method (Table 1).
High resolution TEM of EcN and EcN tolR
To evaluate whether mutation in the Tol-Pal complex induced changes in the ultra-structure
of EcN and its MVs, EcN and EcN tolR strains were examined by TEM following HPF-FS.
Analysis of TSA solid cultures revealed important differences in the amount and morphology
of MVs released into the extracellular space. For EcN, few MVs were observed between cells
(Fig 3A, arrows), while in sections of EcN tolR a huge amount of spherical structures appeared,
mainly interspersed among cells (Fig 3B, arrows), confirming its hypervesiculating phenotype.
After examining 30 fields in sections from wild-type and mutant strains in two replicates, the
Fig 1. Effect of a tolR mutation on EcN growth and vesicle size. (A) Growth curves of wild-type EcN
(cross) and EcN tolR (triangles) cultivated in LB medium. Values are means ± standard error from three
independent experiments. (B) Negative staining electron microscopy of MVs released by these strains after
15 h growth in LB. For both strains, MVs were collected from a 1-litre culture and resuspended in a final
volume of 0.2 ml. Representative images of MV samples from wild-type EcN (direct inspection) and EcN tolR
(1:20 dilution) are shown. Scale bars: 200 nm.
doi:10.1371/journal.pone.0169186.g001
Table 1. MV production of EcN and EcN tolR strains determined by three methods.
EcN EcN tolR Δ MVs
Proteina 0.42 ± 0.03 13.01 ± 1.42 32.9* ± 7.04
LPSb 0.11 ± 0.04 5.20 ± 2.04 51.95* ± 29.72
RFU/CFUc 1.16 E-03 ± 3.7 E-04 8.26 E-02 ± 8.5 E-03 77.78* ± 22.03
Values are the means ± standard error from three independent experiments.
a expressed as mg/L culture
b expressed as mmol KDO/L culture
c MVs lipid fluorescence was measured after incubation with FM4-64, and expressed as relative fluorescence units(RFU)/ by colony forming units (CFU)
ΔMVs, means increase in EcN tolR vesicle production relative to EcN.
* differences are statistically significant (p<0.05) according to Krustal-Wallis H test.
doi:10.1371/journal.pone.0169186.t001
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number of MVs in each field was quantified using markers from the software ImageJ-win64,
and the mutant strain was found to produce 94.7 ± 27.4-fold more MVs than the wild-type
strain.
The morphology of MVs differed notably between the strains. Most of those produced by
EcN corresponded to the commonly named outer membrane vesicles (OMVs). Deriving from
the cell outer membrane, OMVs are surrounded by a bilayer membrane and entrap cyto-
plasmic content, and have diameters smaller than 200 nm (Fig 3C, arrow heads). However, the
EcN tolR mutant produced different types of MVs: some corresponded to the OMV type, with
a normal variation in diameter between 20 and 200 nm (Fig 3D, arrows), but several atypical
MVs were also detected. One type contained two bilayers, similarly to the outer-inner mem-
brane vesicles (O-IMVs) previously described by our group [26] (Fig 3D, black arrow head).
Another type showed three concentric bilayers (Fig 3D, white arrow). An additional singular-
ity was the presence of small groups of between two and four MVs surrounded by a bilayer
(Fig 3D, white arrow head). The diameter of the EcN tolR MVs was more variable and on aver-
age slightly bigger than that of EcN MVs. In some of the fields, larger (about 400 nm) and
apparently empty MVs also appeared, which may correspond to re-annealed membranes from
lysed cells (Fig 3B, asterisks). Additionally, fragments of bilayer membranes, partially circular-
ized but not closed, were observed (Fig 3D, asterisks).
TEM observation of sections obtained after HPF-FS also revealed differences in cell mor-
phology between EcN and EcN tolR. For EcN tolR, a high number of altered cells with variable
Fig 2. Protein profile and immunoblotting of LPS of MVs isolated from EcN and EcN tolR strains. (A)
Comparison of the protein profile of MVs from EcN and EcN tolR. Isolated vesicles (10 μg protein) were
separated in a 10%-SDS-PAGE gel and stained with Sypro® Ruby Protein Gel Stain. Molecular size markers
are indicated. Seven protein bands (labelled by numbers) were excised from the gel and analyzed by LC-MS/
MS (data from these analyses are provided in S1 Table). (B) The name of the protein with the highest score is
indicated for each band. (C) Western blot analysis of LPS in MVs isolated from EcN and EcN tolR strains. MV
samples (0.1μg protein) were separated in a 15%-SDS-PAGE gel and analysed with specific anti-E. coli LPS
antibodies. Representative SDS-PAGE and blots from three independent experiments are shown.
doi:10.1371/journal.pone.0169186.g002
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morphology were perceived, including length, diameter and cell shape. Such differences have
also been reported for tolR mutants of other Gram-negative bacteria [20,39,40].
Cryo-TEM of MVs from EcN and EcN tolR
To further characterize MV structure, cryo-TEM analysis was performed. For this purpose,
total MVs from both strains were isolated from liquid cultures, and the higher diversity in the
types of MVs produced by EcN tolR was confirmed (Fig 4). In EcN samples (Fig 4A), single-
bilayer OMVs predominated in all observed fields (Fig 4, A1), but double-bilayer vesicles
(O-IMVs) (Fig 4, A2) were occasionally detected, as in the previous HPF-FS TEM observa-
tions. In contrast, EcN tolR-derived MVs analyzed by cryo-TEM showed a range of MV types,
many of which did not correspond to the common OMVs or O-IMVs model (Fig 4B). In addi-
tion to OMVs (Fig 4, B1) and O-IMVs (Fig 4, B2), multilayered MVs were often observed (Fig
4, B3), as well as small groups of MVs surrounded by a bilayer (Fig 4, B4), and fragments of
partially circularized bilayer membranes (Fig 4, B5). Altogether, the electron and cryo-electron
Fig 3. TEM micrographs of ultrathin sections from EcN and EcN tolR strains prepared by HPF-FS. (A) A representative
micrograph of EcN cells in which few MVs are observed (arrows). (B) A representative micrograph of EcN tolR cells in which a huge
amount of MVs can be observed interspersed among cells (arrows). Asterisks indicate bigger empty vesicles. (C) A magnified view of
EcN cells in which a common OMVs with one bilayer is observed (arrow). (D) A magnified view of EcN tolR cells in which the following
types of MVs are seen: common MVs (OMVs) indicated by black arrows; two bilayer vesicles (O-IMVs) by black arrow heads; multi-
layered vesicles by white arrows; grouped vesicles by white arrow heads, and partially circularized membranes by asterisks.
Representative images of thin-sections from two different experiments are shown. Bars A–B are 1μm, C–D are 200 nm.
doi:10.1371/journal.pone.0169186.g003
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Fig 4. Isolated MVs from EcN and EcN tolR strains observed by cryo-TEM. (A) A representative image of EcN MVs, in
which two types of MVs can be seen. The most abundant correspond to common OMVs (magnified view A1). A few of the
recently described MVs named O-IMVs (magnified in view A2) were also observed. (B) A representive image of EcN tolR
MVs showing different vesicle types. Magnified views are shown on the right: (B1) common OMVs; (B2) O-IMVs; (B3) multi-
layered vesicles; (B4) grouped vesicles; (B5) partially circularized membranes. Representative images of plunge-frozen
MVs from two different batches of MVs isolated from each strain are shown. Scale bars: 500 nm.
doi:10.1371/journal.pone.0169186.g004
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microscopy studies confirmed the existence of substantial heterogeneity in the structure of
MVs from the EcN tolR mutant.
EcN tolR-derived MVs are not cytotoxic
MVs produced by EcN are not cytotoxic to HT-29 cells [37]. To test whether the different
vesicular structures produced by the tolR mutant could affect cell viability, we examined the
impact of EcN tolR-derived MVs on Caco-2 cell growth. To this end, kinetic studies were per-
formed in Caco-2 cells exposed to EcN tolR MVs (5 μg/ml) or EcN MVs (as a control) for up
to 168 h. Cell numbers were calculated by trypan blue exclusion assays carried out every sec-
ond day during the experiment. Results showed that cell viability was not altered by treatment
with EcN tolR MVs. No significant differences in the percentage of viable cells were observed
after exposure to MVs compared to untreated controls during the incubation period, which
was between 95% and 99% in all cases (S3 Fig).
Uptake of EcN- and EcN tolR-derived MVs by intestinal epithelial cells
We have recently shown that EcN MVs are internalized in Caco-2 cells [28,37]. The presence
of several types of MV structures in the samples isolated from the mutant strain EcN tolR
prompted us to analyze whether this heterogeneous population of MVs could be internalized
by Caco-2 cells. To this end, MVs were labelled with rhodamine B-R18, whose fluorescence is
quenched when intercalated into bilayer membranes at a high concentration. However, this
dye fluoresces when diluted upon membrane fusion and internalization. As expected, no
changes in fluorescence emission were observed in non-treated cells or samples containing
only labelled MVs, whereas rhodamine B-R18-labelled EcN MVs (1 μg protein/well) applied to
the apical side of differentiated Caco-2 cells produced a time-dependent increase in fluores-
cence. Interestingly, the fluorescence level observed in cells incubated with an equal amount of
EcN tolR MVs was significantly lower (Fig 5A; # p<0.02). Confocal fluorescence microscopy
analysis confirmed a reduced uptake by Caco-2 cells of the EcN tolR-derived MVs. Immunos-
taining of the peripheral membrane-associated protein ZO-1 was performed as an epithelial
cell membrane marker (S4 Fig). Representative images captured under the same laser intensity
for internalized EcN and EcN tolR vesicles after 1 h incubation with an equal amount of rhoda-
mine B-R18-labelled MVs are shown in Fig 5B. Previous studies performed in several epithelial
cell lines showed that MVs from wild-type EcN enter intestinal epithelial cells through cla-
thrin-mediated endocytosis [37]. To check whether this endocytic pathway is also responsible
for the uptake of EcN tolR-derived MVs, time-course internalization experiments using rhoda-
mine B-R18-labeled MVs were performed in Caco-2 cells in the presence of inhibitors of endo-
cytosis pathways. MV internalization was not reduced by disruption of lipid raft microdomains
and caveolae by filipin III, but was drastically inhibited by chlorpromazine, an inhibitor of the
clathrin-mediated pathway (Fig 5C). Thus, in spite of the heterogeneity in MVs produced by
the tolR mutant, the entry pathway does not differ from that of wild-type MVs. As for EcN
MVs, internalization of MVs from EcN tolR by undifferentiated Caco-2 cells was also specifi-
cally inhibited by chlorpromazine, but not by filipin III (not shown).
To confirm the different capacity of wild-type and tolR-derived MVs to become internal-
ized by Caco-2 cells, we carried out flow cytometry experiments using MVs labelled with the
fluorescent membrane dye DiO, which has different florescence properties from the lypophylic
dye rhodamine B-R18. To distinguish internalized from cell surface-bound MVs, extracellular
DiO-MV fluorescence was quenched with trypan blue. Results presented in Fig 5D show that
DiO-labelled MVs from both strains were bound and internalized in Caco-2 cells in a time-
dependent manner. However, the ability of MVs to bind and enter epithelial cells differed
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Fig 5. MV uptake by Caco-2 cells. (A) Rhodamine B-R18-labeled MVs (1 μg protein) from EcN (closed squares) or EcN
tolR (open squares) were applied to polarized Caco-2 cells and fluorescence was measured over time. Caco-2 cells
(circles) and MVs (triangles) alone were used as controls of background fluorescence. Values are means ± standard error
from three independent experiments. Statistical differences were assessed using one-way ANOVA followed by Tukey’s
test. *P<0.02, cells incubated with labeled MVs versus the background fluorescence emitted by MVs alone; # P<0.02, cells
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significantly between wild-type and tolR strains. The mean fluorescence intensities after 2 h
and 4 h incubation were significantly lower for EcN tolR vesicles, thus confirming their
reduced capacity for epithelial cell entry. Interestingly, the percentage of cell-associated MVs
(in the absence of trypan blue) that are internalized (in the presence of trypan blue) did not sig-
nificantly differ between wild-type and tolR MVs (Fig 5D). These results indicate that the
lower internalization of EcN tolR-derived MVs could be explained by their reduced ability to
bind epithelial cell membranes. Notably, even for the wild-type EcN, not all cell-associated
MVs were internalized. It has been described that the abilities of MVs to bind and enter epithe-
lial cells depend on the cell line used [41,42]. Studies performed with DiO-labelled MVs from
enterohaemorrhagic E. coli show a lower proportion of internalized MVs in Caco-2 cells than
in other cell lines [42], with fluorescence intensity values comparable to those measured here
in Caco-2 cells incubated with EcN MVs.
Discussion
The study of extracellular vesicles is an ongoing research area, not only in mammalian cells
but also in bacteria [43]. MVs are considered intercellular communicasomes, as they act as a
mechanism for distance delivery of active compounds between cells. In this context, MVs
released by commensal bacteria are foreseen as key players in signaling processes in the
intestinal mucosa [4]. Although still few, the reports on microbiota-produced MVs prove
that they promote immunomodulatory effects in intestinal epithelial and immune cells, as
well as in vivo models [28,44]. The ability of bacterial MVs to interact with and enter host
cells has prompted the exploration of their potential for novel clinical and biotechnological
applications [6,11,45].
As stated above, a major drawback of such applications of bacterial MVs is the very low
yield of MVs isolated from in vitro cultures. One strategy to overcome this limitation is the use
of cell envelope protein mutants with a hypervesiculating phenotype. In this context, mutants
in the tol-pal system have been constructed in various bacterial species to increase MV produc-
tion. Although analysis by negative stain-TEM has revealed that MVs released by tol mutants
display the normal features of bacterial MVs, some differences in the protein content, immu-
nogenicity, and pro-inflammatory properties have been reported for H. pylori ΔtolB and Δpal
mutants [20]. These findings clearly point to differences in the molecular composition of MVs
incubated with EcN tolR-derived MVs versus cells incubated with EcN MVs. (B) Visualization of internalized MVs by
florescence microscopy. Caco-2 cells were incubated with rhodamine B-R18-labeled MVs for 1 and 3 h at 37˚C.
Internalized rhodamine B-R18-labeled MVs are visualized in red. Analysis was performed in a Leica TCS SP5 laser
scanning confocal spectral microscope with a 63x oil immersion objective lens, and images were captured with a Nikon
color camera (16 bit). Scale bars: 20 μm. (C) Internalization of EcN tolR-derived MVs in the presence of endocytosis
inhibitors. Caco-2 cells were pre-incubated for 1h at 37˚C with the lipid raft disrupting agent filipin III (gray diamonds) or with
the clathrin-mediated endocytosis inhibitor chlorpromazine (gray circles) before adding rhodamine B-R18-labeled OMVs
(1 μg/well) from the EcN tolR mutant. Uptake experiments were performed in the absence of endocytosis inhibitors for
comparison (open squares). Fluorescence intensity was normalized by fluorescence detected at the indicated time points
by labeled MVs in the absence of cells (black triangles). Data are presented as means ± standard error from three
independent experiments. Statistical differences were assessed using one-way ANOVA followed by Tukey’s test. Values
significantly different from those of cells incubated with MVs in the absence of endocytosis inhibitors are indicated by an
asterisk (*p<0.02). (D) Caco-2 cells were incubated with DiO-labeled OMVs (100 μg/ml protein) from strains EcN and EcN
tolR for the indicated times and fluorescence was measured using a flow cytometer before (total cell-associated OMVs) and
after (internalized OMVs) trypan blue quenching. Data are expressed as means of fluorescence intensities from 10,000
cells after subtraction of background fluorescence of cells without OMVs (means ± standard error from three independent
experiments). Statistical differences were assessed using one-way ANOVA followed by Tukey’s test. Significance between
cells incubated with EcN tolR-derived MVs versus cells incubated with EcN MVs (*p0.02; ** p0.002). The table on the
right shows the percentage of internalized MVs for each sample and incubation time (internalized / total cell-associated
MVs).
doi:10.1371/journal.pone.0169186.g005
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isolated from tol mutants and call for a more in-depth knowledge of MV structure before their
application in functional studies or for biotechnological purposes.
To gain further insight into the molecular structure of MVs released by tol system mutants,
we used the probiotic strain EcN as a model. MVs from EcN and the derived tolR mutant were
isolated after 15 h of growth, as functional studies are often performed with MVs collected
from overnight cultures (from 12 to 15 h growth) [9,29,42,46–47]. As in tolR mutants derived
from other Gram-negative bacteria [48], the EcN tolR growth curve was similar to that of the
wild-type EcN. Although minor differences in the growth rate were observed during the early
exponential phase, both strains exhibited equal cell numbers and OD580 values during the late
exponential and early stationary phases. Highly vesiculating phenotypes have been described
for many E. coli tol-pal mutants [13,19], so it was not surprising that EcN tolR exhibited signifi-
cant increases in MV production compared to the wild-type strain, ranging from 32.9- to
77.8-fold, according to the quantification method. Relative values of vesicle production based
on fluorescent lipid measurement were higher than with protein analysis, as reported in other
studies [13]. Although the greater amounts of protein, LPS or lipids in the tolR mutant could
be due to a larger vesicle size, the slight increase in tolR MV size observed was not enough to
justify the 32.9-fold or higher increases measured with the three methods.
While the protein profile of EcN tolR-derived MVs was quite similar to that of the MVs iso-
lated from the wild-type strain, some differences were identified. The most relevant differences
correlate with disturbances in the outer membrane structures, likely resulting from TolR defi-
ciency. Thus, MVs released by the tolR mutant displayed a higher content of TolB (periplasmic
protein) and Pal (outer membrane protein), two proteins of the Tol-Pal complex. As formation
of the heteromultimeric protein complex TolQRA-B-Pal is altered as a consequence of TolR
deficiency, non-interacting TolB and Pal proteins could then be released through MVs. As
for Gallibacterium anatis tolR mutants [48], the MVs produced by the EcN tolR mutant were
enriched in OmpA. This abundant outer membrane protein also contributes (like the Tol-Pal
system) to linking PG to the outer membrane. It has been suggested that increased OmpA lev-
els may compensate for the membrane instability in Tol-Pal-deficient strains [48]. On the
contrary, both the scaffold protein MipA required for PG biosynthesis and flagellin were
underrepresented in EcN tolR MVs. A low production of flagella has also been reported for a
H. pylori tolB mutant, and the released MVs similarly showed specific differences in protein
composition with respect to those produced by wild-type H. pylori, with about ten proteins
absent in those of the mutant strain [20]. Overall, we can conclude that the main alterations in
the molecular composition of EcN tolR-derived MVs may be attributed to TolR deficiency.
The composition of MVs obtained from tolR mutants has been studied by several groups,
but the MV structure has generally not been analyzed in detail. TEM observation of negatively
stained MVs is the most commonly used technique to assess MV presence and morphology,
but it does not provide enough resolution to distinguish between different types of MVs, arti-
facts, or re-circularized membranes from lysed cells [13,19,22,23,49,50]. Some studies have
described vesicle morphology by scanning electron microscopy (SEM) or thin-section TEM of
chemically fixed and dehydrated samples at room temperature [14,15,51–53]. However, in
both methods the extracellular matter, which includes MVs, has a marked propensity to col-
lapse and be removed during sample preparation [2,54]. Surprisingly, few studies have used
TEM of cryo-immobilized specimens by HPF followed by FS, or cryo-TEM to visualize MV
samples, although both have proven very useful for observing detailed structures of MVs and
their producing strains [26,27,34,55,56].
In this study, when TEM of negatively stained MVs was used to compare structural differ-
ences between vesicles from EcN and EcN tolR, only a slight increase in the mean diameter of
EcN tolR vesicles was observed and a lower small vesicle population; no details other than their
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spherical shape and size were appreciated with this technique. Conversely, TEM observation
of thin-sections of HPF-FS samples from both strains allowed us to visualize the higher MV
production by EcN tolR, and that different types of MVs were interspersed among cells. The
presence of different types of MVs was further confirmed by cryo-TEM observation of plunge
frozen-hydrated isolated MVs, which is the less artifactual technique. In EcN samples, two
types of MVs were observed, most corresponding to common OMVs and a few to the recently
described O-IMVs [26,27]. On the other hand, cryo-TEM of EcN tolR samples revealed at least
five types of hypothetical MVs. The presence of different types of MVs, including trilayered
MVs, or whorled outer membrane fragments, has also been confirmed in an ultrastructural
analysis of MVs from Helicobacter pylori strain 60190 [52].
The protein / fluorescent lipid ratio did not return the same value for EcN and EcN tolR
MVs, the tolR mutant ratio being less than half that of the wild-type strain. This lack of correla-
tion can be explained by the different types of MVs produced by the tolR mutant, in which the
protein-to-lipid ratio was not maintained when compared with wild-type MVs. TEM and cryo-
TEM observations confirmed both the over-vesiculation phenotype of EcN tolR and the variety
of shapes of tolR MVs. Considering the morphological diversity of MVs, many of which had
multilayered lipid bilayers, it seems reasonable that the protein-to-lipid ratio is lower in tolR
MVs. Analyzing MVs structure by TEM after HPF-FS and cryo-TEM techniques, instead of
relying only on electron microscopy of negative stained MVs, allowed us to obtain complemen-
tary and more accurate information about the over-vesiculating EcN mutant strain.
Although it cannot be discarded that some cell lysis may have contributed to the high
amount of MVs produced by the tolR mutant, we can rule out that the over-vesiculation and
changes in MV morphology were due to impaired growth or cell lysis, since both strains exhib-
ited normal growth with identical cell counts and OD580 at the time of vesicle collection. One
hypothesis is that MVs from EcN tolR are unstable and break easily. Rennelli and co-workers
[56] explored this possibility by cryo-TEM and established that only 7.3% of MVs from Pseu-
domonas aeruginosa PAO1 were broken. A similar proportion was observed in EcN mutant
MVs, which would not explain the marked increase in vesiculation.
Our study shows that not only can the composition and structure of MVs be modified by
mutations in the cell envelope proteins, but their interaction with target cells can also be
affected. Analysis of MV uptake, measured by the increase in rhodamine-emitted fluorescence
and microscope imaging, indicated a reduced level of internalized vesicles derived from the
EcN tolR mutant. Quantification of the fluorescence emitted upon internalization in Caco-2
cells allowed us to estimate a roughly 3-fold reduction in the number of intracellular MVs in
comparison with wild-type-derived MVs. Interestingly, tolR-derived MVs are internalized by
the same endocytic pathway as EcN MVs, as their uptake is impaired in the presence of the cla-
thrin-mediated endocytosis inhibitor chlorpromazine. Flow cytometry analysis performed
with DiO-labelled OMVs confirmed the lower internalization values for tolR-derived MVs. In
addition, fluorescence intensity values before and after trypan blue addition allowed us to
establish that the low number of internalized MVs was due to a lower cell binding capacity of
the tolR-derived MVs, rather than a different entry pathway or mechanism. These results sug-
gest that only certain types of MVs, most likely conventional OMVs and O-IMVs, efficiently
interact with their target(s) or receptor(s) in the cell membrane, a key step before being taken
up by epithelial cells through clathrin-mediated endocytosis.
Conclusions
High yields in MV production are desirable if the MVs are to be used for functional studies or
biotechnological purposes. Independently of the strategy used to increase production yield,
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there is a need to obtain a well-defined and uniform pool of MVs. Our study confirms that the
introduction of a tolR mutation in the probiotic EcN induces a hypervesiculation phenotype.
MVs retrieved from the mutant strain showed alterations in composition and in their ability to
interact with host cells, which can be explained by significant modifications in MV structure.
Production of different types of MVs or outer membrane structures by tolR mutants cannot be
detected by TEM of negatively stained MVs, although this heterogeneity may have a major
impact on MV functionality. This study evidences the need for conducting a detailed structural
analysis by high resolution TEM techniques when working with hypervesiculating mutants.
This analysis is crucial to improve and standardize the MVs used for therapy purposes.
Supporting Information
S1 Fig. PCR confirmation of tolR disruption in EcN. The mutant strain EcN tolR was con-
structed by P1-transduction from E. coli strain TPS300 (tolR::Ocm). The correct integration
of the tolR::Ocm marker in the EcN genome was assessed by PCR amplification with the
primers flanking tolR sequences: FW-tolR (TGCGCCGGAAGCCGTAGTGG) and RV-tolR
(CCGCTTGTTTCTCACGCAGT).The size of the amplified products is indicated on the left. The
increase in the size of the PCR product in the EcN tolR mutant confirms tolR disruption by the
chloramphenicol cassette as in the donor strain TPS300.
(PDF)
S2 Fig. Growth curves of EcN (cross) and EcN tolR (triangles) cultivated in LB medium
monitored by viable counts (colony forming units, CFU/ml).
(TIF)
S3 Fig. Effect of EcN and EcN tolR-derived OMVs on viability of Caco-2 cells. Cell viability
of Caco-2 cells exposed to OMVs (5 μg/ml) from EcN (blue) or EcN tolR (orange) for up to 7
days, measured by the trypan blue exclusion assay. Untreated Caco-2 cells (gray) were ana-
lyzed in parallel as a control. Values are means ± standard error from three independent exper-
iments. Lack of statistical differences was confirmed by one-way ANOVA followed by Tukey’s
test.
(TIF)
S4 Fig. Visualization of internalized MVs by fluorescence microscopy. Caco-2 cells were
incubated with rhodamine B-R18-labeled MVs, isolated from the indicated strains, for 1 hour
at 37˚C. The cell membrane was visualized by immunostaining with antibodies against the
zonula occludens ZO-1 protein followed by Alexa Fluor 488-conjugated secondary antibody
(green). Nuclei were stained with DAPI (blue). Internalized labeled MVs are visualized in red.
Representative images from three independent experiments are shown. Scale bars: 20 μm.
(TIF)
S1 Table. Proteomic analysis by LC-MS/MS. Identification of gel-excised seven protein
bands labelled by numbers in Fig 2, which were differentially expressed between EcN and EcN
tolR.
(XLSX)
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